completed seed round. Initiating Series A $10M-$15M. Prioritizing lead therapeutic candidate for cancer and acute viral infections.
This is where a company's traction statement would be visible. As you are not logged in, you cannot see it. When you become an advisor you'll be able to view the traction.
A clinical-stage biopharmaceutical company dedicated to advancing oncology outcomes through the development of next-generation bifunctional antibodies.
Fundraising: pitching, angels and VC rounds; grants & government funding; deal terms
This is where you can find what a company would like mentoring on. The field will become available when you are onboarded.
3
